Atia Vision Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $42M

  • Investors
  • 10

Atia Vision General Information

Description

Developer of presbyopia-correcting medical devices designed to provide accommodating intraocular lenses. The company's devices naturally mimic the physiological lens's autofocusing capability without creating visual artifacts and its accommodating intraocular lens eliminates the need for glasses, thus restoring vision, enabling cataract and vision-impaired patients with an effective range of vision treatment.

Contact Information

Formerly Known As
Atia Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 550 Division Street
  • Campbell, CA 95008
  • United States
+1 (408)
Primary Industry
Therapeutic Devices
Corporate Office
  • 550 Division Street
  • Campbell, CA 95008
  • United States
+1 (408)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atia Vision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series E) 02-Aug-2022 $42M Completed Clinical Trials - General
5. Later Stage VC (Series D) 26-Apr-2019 Completed Clinical Trials - General
4. Later Stage VC (Series C) 09-Nov-2018 Completed Clinical Trials - General
3. Later Stage VC (Series C) 08-May-2017 Completed Clinical Trials - General
2. Early Stage VC (Series B) 01-Apr-2015 $5M $6.11M Completed Clinical Trials - General
1. Early Stage VC (Series A) 05-Sep-2013 $1.11M $1.11M Completed Clinical Trials - General
To view Atia Vision’s complete valuation and funding history, request access »

Atia Vision Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B
Series A1 1,692,328 $0.000100 $0.03 $0.42 $0.42 1x $0.42 3.68%
Series A 2,750,000 $0.000100 $0.01 $0.18 $0.18 1x $0.18 5.98%
To view Atia Vision’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Atia Vision Patents

Atia Vision Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250235308-A1 Accommodating intraocular lens Pending 26-Aug-2014
FR-1368119-A Process for protecting plants against the effects of frost Inactive 21-Jan-1963

Atia Vision Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atia Vision Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
PA MedTech VC Fund Corporate Venture Capital Minority
AMED Ventures Venture Capital Minority
ShangBay Capital Venture Capital Minority
Cormorant Asset Management PE/Buyout Minority
Grant Park Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Atia Vision FAQs

  • When was Atia Vision founded?

    Atia Vision was founded in 2012.

  • Where is Atia Vision headquartered?

    Atia Vision is headquartered in Campbell, CA.

  • What is the size of Atia Vision?

    Atia Vision has 15 total employees.

  • What industry is Atia Vision in?

    Atia Vision’s primary industry is Therapeutic Devices.

  • Is Atia Vision a private or public company?

    Atia Vision is a Private company.

  • What is the current valuation of Atia Vision?

    The current valuation of Atia Vision is .

  • What is Atia Vision’s current revenue?

    The current revenue for Atia Vision is .

  • How much funding has Atia Vision raised over time?

    Atia Vision has raised $78.1M.

  • Who are Atia Vision’s investors?

    PA MedTech VC Fund, AMED Ventures, ShangBay Capital, Cormorant Asset Management, and Grant Park Ventures are 5 of 10 investors who have invested in Atia Vision.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process